Skip to main content
SpringerLink
Log in

Prophylactic calcium and vitamin D treatments in steroid-treated children with nephrotic syndrome

  • Original Article
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

Steroid treatment has several side effects, including the deterioration of the bone and mineral metabolism in children with nephrotic syndrome. This randomized prospective study was conducted to determine the effects and prophylactic role of calcium plus vitamin D treatment on bone and mineral metabolism in children receiving prednisolone treatment. 40 children (27 boys and 13 girls) with NS (18 new onset and 22 relapsing) were included in the study. Their mean age was 4.6±1.8 years. All patients received prednisolone treatment (2 mg/kg/day for 4 weeks followed by alternate days at the same dose for 4 weeks). The patients were randomized into treatment (vitamin D 400 IU plus calcium 1 g daily) and non-treatment groups. Bone mineral density, serum Ca, P, alkaline phosphatase and urinary Ca and P excretions were analyzed at the beginning and 2 months after the treatment. The XR36 Norland device was used for bone mineral density analysis. Bone mineral density was significantly decreased in both the treatment (0.54±0.15 to 0.51±0.1 g/cm2, P =0.001) and non-treatment (0.52±0.18 to 0.45±0.16 g/cm2, P <0.001) group. But the percentage of bone mineral density decrease was found to be significantly lower in the treatment group than in the non-treatment group (4.6±2.1% vs. 13.0±4.0%, respectively; P <0.001). Serum calcium and urinary calcium excretion increased in the treatment group (8.0±1.0 to 10.0±0.5 mg/dl and 1.1±0.5 to 3.2±1.0 mg/kg/day) and non-treatment group (8.1±0.8 to 10.0±0.6 mg/dl and 1.4±0.9 to 3.8±3.3 mg/kg/day) after prednisolone treatment (P <0.001). Steroid treatment decreases bone mineral density in children with nephrotic syndrome. Vitamin D plus calcium therapy at the current doses reduces but does not completely prevent bone loss, with no additional adverse effects.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Shaw NJ, Bishop NJ (1995) Mineral accretion in growing bones—a framework for the future? Arch Dis Child 72:177–179.

    PubMed  Google Scholar 

  2. Chesney RW, Mazess RB, Rose P, Jax DK (1978) Effect of prednisolone on growth and bone mineral content in childhood glomerular disease. Am J Dis Child 132:768–772

    PubMed  Google Scholar 

  3. Lettgen B, Jeken C, Reiners C (1994) Influence of steroids medication on bone mineral density in children with nephrotic syndrome. Pediatr Nephrol 8:667–670

    Article  PubMed  Google Scholar 

  4. Morin D, Kotski PO, Dalla Vale F, Rossi M, Dumas R (1996) Bone mineral density in children with steroid sensitive nephrotic syndrome. Pediatr Nephrol 10:C147

    Google Scholar 

  5. Emerson K, Beckman WW (1945) Calcium metabolism in nephrosis: A description of an abnormality in calcium metabolism in children with nephrosis. J Clin Invest 24:564–572

    Google Scholar 

  6. Biyikli Karaslan N, Emre S, Sirin A, Bilge I (2004) Biochemical bone markers in nephrotic children. Pediatr Nephrol 19:869–873

    Article  PubMed  Google Scholar 

  7. Freundlich M, Jofe M, Goodmann WG, Salusky IB (2004) Bone histology in steroid treated children with non-azotemic nephrotic syndrome. Pediatr Nephrol 19:400–407

    Article  PubMed  Google Scholar 

  8. Neyzi O, Bundak R (2002) Büyüme. In: Neyzi O, Ertugrul T (eds) Pediatri, Nopel Tıp Kitapevi, pp 85–99

  9. Grymonprez A, Proesmans W, Van Dyck M, Jans I, Goos G, Bouillon R (1995) Vitamin D metabolites in childhood nephrotic syndrome. Pediatr Nephrol 9:278–281

    Article  PubMed  Google Scholar 

  10. Colston K, Williams NJ, Cleeve HJ (1985) Studies on vitamin D binding protein in the nephrotic syndrome. Clin Chem 31:718–721

    PubMed  Google Scholar 

  11. Mittal SK, Dash SC, Tiwari SC, Agarwal SK, Saxena S, Fishbane S (1999) Bone histology in patients with nephrotic syndrome and normal renal function. Kidney Int 55:1912–1919

    Article  PubMed  Google Scholar 

  12. Freundlich M, Bourgoignie JJ, Zilleruelo G, Jacob AI, Canterbury JM, Strauss J (1985) Bone modulating factors in nephrotic children with normal glomerular filtration rate. Pediatrics 76:280–285

    PubMed  Google Scholar 

  13. Alon U, Chan JC (1983) Calcium and vitamin-D metabolism in nephrotic syndrome. Int J Pediatr Nephrol 4:115–118

    PubMed  Google Scholar 

  14. Chesney RW, Mazess RB, Rose PG, Jax DK (1977) Bone mineral status measured by direct photon absorbtiometry in childhood renal disease. Pediatrics 60:864–872

    PubMed  Google Scholar 

  15. Chesney RW, Mazess RB, Hamstra AJ, DeLuca HF, O’Reagan S (1978) Reduction of serum-1, 25-dihydroxyvitamin-D3 in children receiving glucocorticoids. Lancet 2:1123–1125

    Article  PubMed  Google Scholar 

  16. Takeda Y (1993) Evaluation of bone mineral turnover in children with nephrotic syndrome—the implications of original disease and the effects of corticosteroids on bone metabolism. Nippon Jinzo Gakkai Shi 35:705–713

    PubMed  Google Scholar 

  17. Polito C, La Manna A, Todisco N, Cimmaruta E, Sessa G, Pirozzi M (1995) Bone mineral content in nephrotic children on long-term, alternate-day prednisone therapy. Clin Pediatr (Phila) 34:234–236

    Google Scholar 

  18. Esbjorner E, Arvidsson B, Jones IL, Palmer M (2001) Bone mineral content and collagen metabolites in children receiving steroid treatment for nephrotic syndrome. Acta Paediatr 90:1127–1130

    Article  PubMed  Google Scholar 

  19. Leonard MB, Feldman HI, Shults J, Zemel BS, Foster BJ, Stallings VA (2004) Long-term, high-dose glucocorticoids and bone mineral content in childhood glucocorticoid-sensitive nephrotic syndrome. N Engl J Med 26:868–875

    Article  Google Scholar 

  20. Fujita T, Satomura A, Hidaka M, Ohsawa I, Endo M, Ohi H (2000) Acute alteration in bone mineral density and biochemical markers for bone metabolism in nephrotic patients receiving high-dose glucocorticoid and one-cycle etidronate therapy. Calcif Tissue Int 66:195–199

    Article  PubMed  Google Scholar 

  21. Yonemura K, Hishida A, Kimura M, Watanabe T, Kumagai H (1999) Prednisolone induces an increase in serum calcium concentration: possible involvement of the kidney, the bone, and the intestine. Calcif Tissue Int 65:267–271

    Article  PubMed  Google Scholar 

  22. Gulati S, Godbole M, Singh U, Gulati K, Srivastava A (2003) Are children with idiopathic nephrotic syndrome at risk for metabolic bone disease? Am J Kidney Dis 41:1163–1169

    Article  PubMed  Google Scholar 

  23. Pocock NA, Noakes KA, Majerovic Y, Griffiths MR (1997) Magnification error of femoral geometry using fan beam densitometers. Calcif Tissue Int 60:8–10

    Article  PubMed  Google Scholar 

  24. Blake GM, Parler JC, Buxton FM, Fogelman I (1993) Dual x-ray absorptiometry: a comparison between fan beam and pencil beam scans. Br J Radiol 66:902–906

    PubMed  Google Scholar 

  25. Tothill P, Avenell A (1994) Errors in dual-energy X-ray absorptiometry of the lumbar spine owing to fat distribution and soft tissue thickness during weight change. Br J Radiol 67:71–75

    PubMed  Google Scholar 

  26. Tothill P, Avenell A (1998) Anomalies in the measurement of changes in bone mineral density of the spine by dual-energy X-ray absorptiometry. Calcif Tissue Int 63:126–133

    Article  PubMed  Google Scholar 

  27. Korkor A, Schwartz J, Bergfeld M, Teitelbaum S, Avioli L, Klahr S, Slatopolsky E (1983) Absence of metabolic bone disease in adult patients with the nephrotic syndrome and normal renal function. J Clin Endocrinol Metab 56:496–500

    PubMed  Google Scholar 

  28. Tessitore N, Bonucci E, D’Angelo A, Lund B, Corgnati A, Lund B, Valvo E, Lupo A, Loschiavo C, Fabris A, et al (1984) Bone histology and calcium metabolism in patients with nephrotic syndrome and normal or reduced renal function. Nephron 37:153–159

    PubMed  Google Scholar 

  29. Freundlich M, Bourgoignie JJ, Zilleruelo G, Abitbol C, Canterbury JM, Strauss J (1986) Calcium and vitamin D metabolism in children with nephrotic syndrome. J Pediatr 108:383–387

    PubMed  Google Scholar 

  30. Sierra RI, Specker BL, Jimenez F, Cruz C, Pedraza-Chaverri J (1997) Biochemical bone markers, bone mineral content, and bone mineral density in rats with experimental nephrotic syndrome. Ren Fail 19:409–424

    PubMed  Google Scholar 

  31. Weng FL, Shults J, Herskovitz RM, Zemel BS, Leonard MB (2005) Vitamin D insufficiency in steroid-sensitive nephrotic syndrome in remission. Pediatr Nephrol 20:56–63

    Article  PubMed  Google Scholar 

  32. Gulati S, Gulati K (2005) Bone disease in nephrotic syndrome-prevention is better than cure. Pediatr Nephrol 20:111–112

    Article  PubMed  Google Scholar 

  33. Lim P, Jacob E, Tock EP, Pwee HS (1977) Calcium and phosphorus metabolism in nephrotic syndrome. Q J Med 46:327–338

    PubMed  Google Scholar 

  34. Belon C, Dumas R, Jean R, Huguet R (1979) Calcium and phosphorus evaluation during cortisone treatment of nephrotic syndrome in relapse. Arch Fr Pediatr 36:1006–1012

    PubMed  Google Scholar 

  35. Haldimann B, Trechsel U (1983) Vitamin D replacement therapy in patients with the nephrotic syndrome. Miner Electrolyte Metab 9:154–156

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatric Nephrology, Dr. Behcet Uz Children’s Hospital, Izmir, Turkey

    Mustafa Bak & Erkin Serdaroglu

  2. Department of Pediatrics, Dr. Behcet Uz Children’s Hospital, Izmir, Turkey

    Rengin Guclu

  3. , 1374 Sk No 26 C Blok D 8, Alsancak, 35220, Izmir, Turkey

    Erkin Serdaroglu

Authors
  1. Mustafa Bak
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Erkin Serdaroglu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Rengin Guclu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Erkin Serdaroglu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bak, M., Serdaroglu, E. & Guclu, R. Prophylactic calcium and vitamin D treatments in steroid-treated children with nephrotic syndrome. Pediatr Nephrol 21, 350–354 (2006). https://doi.org/10.1007/s00467-005-2118-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-005-2118-z

Keywords

Search

Navigation